Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank86
3Y CAGR-2.4%
5Y CAGR+9.5%
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-2.4%/yr
vs +31.6%/yr prior
5Y CAGR
+9.5%/yr
Recent deceleration
Acceleration
-34.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$88.04M+376.6%
2024$18.47M+145.3%
2023$7.53M-92.0%
2022$94.59M+34.3%
2021$70.43M+26.2%
2020$55.83M+107.8%
2019$26.87M-14.7%
2018$31.50M+135.6%
2017$13.37M-87.4%
2016$106.41M-